Ayvens SA (AYV)
Euronext Paris · France · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 8.730 |
|---|---|
| 52-week range | 8.520 – 12.640 |
| Return, 1 month / 3 months | −14.6% / −25.1% |
| Return, 1 year / 3 years | −4.3% / +75.5% |
| Trend | Below its 200-day average |
| RSI (14) | 30 |
| Volatility (1 year) | 30.2% |
| Worst drawdown (1 year) | -26.6% |
| Average daily value traded | 9.86M EUR |
| Dividend yield | 15.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ayvens is a vehicle leasing and fleet management company formed from the combination of ALD Automotive and LeasePlan. It provides full-service leasing, fleet management and related mobility services to corporate clients, small and medium-sized businesses and individual customers. The company manages cars and light commercial vehicles, handling financing, maintenance and administration for fleets. Ayvens is based in France and serves customers across many countries in Europe and beyond.
On this site Ayvens SA appears as a stock on the Euronext Paris (France), code AYV, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ayvens SA (AYV) trades on the Euronext Paris in France. It last closed at EUR 8.730 on 22 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 217 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.3% and over the last three months it fell 25.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -16.3% | ||
| From 52-week high | -29.9% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -25.1% | ||
| 6-month return | -14.8% | ||
| 12-month return, skipping the last month | 12.1% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.6% | ||
| Liquidity | 89 · Strong | Trades actively. | |
| Average daily value traded | 9.86M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 79 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 15.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −14.6% |
| 3 months | −25.1% |
| 6 months | −14.8% |
| 1 year | −4.3% |
| 3 years | +75.5% |
| 5 years | +14.8% |
Signals
| 50-day / 200-day average | 10.079 / 10.433 |
|---|---|
| Golden / death cross (60 days) | Death, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.229 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Sep 2026 | EUR 0.3200 |
| 20 May 2026 | EUR 0.5900 |
| 16 Dec 2025 | EUR 0.4200 |
| 26 May 2025 | EUR 0.3700 |
| 31 May 2024 | EUR 0.4700 |
| 31 May 2023 | EUR 1.0600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.